Effect of Anterioposterior Weight Shifting Training With Visual Biofeedback in Subacute Stroke

Sponsor
Yonsei University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04637737
Collaborator
(none)
50
1
2
80
0.6

Study Details

Study Description

Brief Summary

Asymmetric gait patterns of stroke is one of the most important functional activities to enable community participation, it is major goal for stroke patients. Reported that the stroke patients had asymmetry at stance time, single stance, double support time, and swing time compared to normal people, and claimed that the most important factor was step length. According to Albert et al., patients with an asymmetric gait pattern have a long double support phase and a healthy side single support phase, and less weight shift to the affected side. Recent studies have shown that visual feedback for weight shift may be helpful to obtain a symmetrical posture after stroke. However, no study has been conducted on the therapeutic effect on gait asymmetry and patterns. We aimed to investigate the effect of Anterioposterior Weight Shifting Training with Visual Biofeedback in subacute post-stroke patients on gait asymmetry and pattern.

40 subacute post-stroke patients with Step Length Asymmetry were enrolled in this study. The subjects were randomly assigned into two groups. The training group received an additional anterioposterior weight shifting training with visual Biofeedback 5 times per week for 4weeks. The control group received the usual gait training. The spatiotemporal and kinematic data were obtained during walking through 3D motion analysis. Functional Ambulation Category, Self-selected walking speed, Maximum safe walking speed, Berg balance Test (BBT), Fugl-Meyer Assessment (FMA), Medical Research Council Score (MRC), Functional Independent Measure-mobility, Timed Up and Go test (TUG) were assessed at pre, during, post- training, and 4week follow-up. Those were compared between two groups by repeated measures ANOVA.

Condition or Disease Intervention/Treatment Phase
  • Device: anterioposterior Weight Shifting Training with Visual Biofeedback
  • Behavioral: Conventional therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Anterioposterior Weight Shifting Training With Visual Biofeedback in Subacute Stroke
Study Start Date :
Oct 1, 2014
Anticipated Primary Completion Date :
Jun 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training group

Device: anterioposterior Weight Shifting Training with Visual Biofeedback
The training group received an additional anterioposterior weight shifting training with visual Biofeedback 5 times per week for 4weeks. AP training is made to instantly know your training status during training by measuring and processing the foot pressure in real time using the F-Scan (Tekscan) hardware system and Software Development Kit (SDK). Before training, all patients are instructed to place both feet at shoulder width, place the inverted foot approximately 30 cm in front of the unaffected side foot, move the body forward with the chest straight in an upright position, and be instructed to put the weight on the affected side. On the screen shown, measure the maximum weight distribution during the first 10 times and set the value added by 5% as the target value. It is designed to induce the maximum weight shift through the archery game.

Other: Control group

Behavioral: Conventional therapy
The control group received the usual gait training.

Outcome Measures

Primary Outcome Measures

  1. Step Length Asymmetric Ratio [before training(0week)]

    Step Length Asymmetric Ratio = paretic step length/non paretic step length

  2. Step Length Asymmetric Ratio [during training(2week)]

    Step Length Asymmetric Ratio = paretic step length/non paretic step length

  3. Step Length Asymmetric Ratio [after training(4week)]

    Step Length Asymmetric Ratio = paretic step length/non paretic step length

  4. Step Length Asymmetric Ratio [Follow up(8week)]

    Step Length Asymmetric Ratio = paretic step length/non paretic step length

  5. Step Length Asymmetric Index [before training(0week)]

    Step Length Asymmetric Index = paretic step length-non paretic step length/0.5[paretic step length +non paretic step length]

  6. Step Length Asymmetric Index [during training(2week)]

    Step Length Asymmetric Index = paretic step length-non paretic step length/0.5[paretic step length +non paretic step length]

  7. Step Length Asymmetric Index [after training(4week)]

    Step Length Asymmetric Index = paretic step length-non paretic step length/0.5[paretic step length +non paretic step length]

  8. Step Length Asymmetric Index [Follow up(8week)]

    Step Length Asymmetric Index = paretic step length-non paretic step length/0.5[paretic step length +non paretic step length]

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. less than 6 months after onset of the stroke

  2. can stand and walk independently 10m

  3. K-MMSE score of at least 15

  4. have asymmetrical gait pattern with Step length asymmetric ratio greater than 1.1

  5. over 20 years of age.

Exclusion Criteria:
  1. quadriplegia

  2. past history of stroke

  3. past history of Musculoskeletal disease or history of Neurological diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine Seoul Korea, Republic of

Sponsors and Collaborators

  • Yonsei University

Investigators

  • Principal Investigator: Deog Young Kim, Severance Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT04637737
Other Study ID Numbers:
  • 4-2014-0383
First Posted:
Nov 20, 2020
Last Update Posted:
Nov 20, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 20, 2020